China Shineway Pharmaceutical Group Limited

CSWYYOTCHealthcare● Active

$19.25

+$0.00(+0.00%)

Market Cap$36353625

P/E Ratio—

52W High$22.54

52W Low$19.25

Avg Volume0.584

Open$22.08

Beta0.71

Net Income Financials Revenue

China Shineway Pharmaceutical Group Limited (CSWYY) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CSWYY · net income · updated Jun 9, 2026

Core profitability metrics

CSWYY · net income · margin · TTM · CAGR

Net income was $924.1M for FY2025 (fiscal year ending 2025-12-31), up 10.0% year-over-year. Net profit margin was 30.3%. Based on available data, China Shineway Pharmaceutical Group Limited has been profitable since at least 2011.

FY2025 Net Income$924.1M▲ +10.0% YoY

Trailing 12M (TTM)$1.78Btrailing 4 quarters sum

Net Profit Margin30.3%$924.1M ÷ $3.05B

YoY Change+10.0%—

5-Year CAGR+25.6%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · CSWYY net income history · CSWYY profit margin

Annual net income data

CSWYY · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$924.1M▲ +10.0%30.3%$3.05B

FY2024$840.1M▼ 13.4%22.2%$3.78B

FY2023$969.5M▲ +34.1%21.5%$4.52B

FY2022$722.8M▲ +29.8%18.0%$4.02B

FY2021$556.7M▲ +88.7%17.5%$3.18B

Net income vs peers (Healthcare)

CSWYY vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

China Shineway Pharmaceutical Group LimitedYOU

CSWYY

$924.1M+10.0%30.3%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

China Shineway Pharmaceutical Group Limited (CSWYY) reported net income of $924.1M for FY2025 (fiscal year ending 2025-12-31), up 10.0% year-over-year. The net profit margin was 30.3% — meaning the company kept $0.30 of every dollar of revenue as profit.

Based on available data, China Shineway Pharmaceutical Group Limited has been profitable since at least 2011. Net income reached a peak of $969.5M in FY2023. Data available for 15 fiscal years.

China Shineway Pharmaceutical Group Limited's net profit margin was 30.3% for FY2025, based on the latest annual results.

Investors sometimes search for "China Shineway Pharmaceutical Group Limited net worth" — the company's market capitalization is a separate figure from CSWYY net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CSWYY net income · 5 questions

China Shineway Pharmaceutical Group Limited is profitable. The company reported net income of $924.1M for FY2025, a net profit margin of 30.3%. Net income was up 10.0% year-over-year. Based on available data, China Shineway Pharmaceutical Group Limited has been profitable since at least 2011.

is CSWYY profitabledoes CSWYY make a profitCSWYY profitabilityCSWYY profitable company

▸ Source: FMP /income-statement · GAAP · China Shineway Pharmaceutical Group Limited · China Shineway Pharmaceutical Group Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026